Gialgan of Pheidias

Гиалган Фидия Drug photo

The description is actual on 22.07.2016

  • Latin name: Hyalgan Fidia
  • ATH code: M09AX01
  • Active ingredient: Hyaluronic acid (Hyaluronic acid)
  • Producer: Fidia Pharmaceutici S.p.A. (Italy)


Sodium hyalrunate, sodium dihydrate dihydrophosphate, dinatrium dodecahydrate hydrophosphate, sodium chloride, water for and.

Release form

Solution for introduction in a joint of 20 mg viscous transparent, colourless in the glass syringe of 2 ml in a blister strip packaging in a cardboard pack No. 1, 5.

Pharmacological action

Antiinflammatory, analgeziruyushchy, adjusting a metabolism of cartilaginous tissue.

Pharmacodynamics and pharmacokinetics


Drug with the antiinflammatory and anesthetizing action. Hyaluronic acid is necessary for process of forming of proteoglycans in a cartilage of joints and maintenance of elasticity and viscosity of synovial fluid.

The osteoarthrosis is followed by a shortcoming and changes of qualitative composition of hyaluronic acid in a cartilage and synovial fluid. Use of drug in the presence of degenerative changes of a surface of a cartilage and change of composition of synovial fluid provides improvement of function of a joint and a clinical current of an osteoarthrosis.


At intra joint introduction within 2–3 days hyaluronic acid is removed from synovial fluid. The maximum concentration of hyaluronic acid is noted in a joint capsule and synovial fluid, in smaller volumes — in a synovial membrane, adjacent muscles and sheaves. The metabolism occurs in a liver and circumarticular fabrics, drug with urine is removed.

Indications to use

In complex treatment of an osteoarthrosis and degenerative posttraumatic changes of joints and improvements of their mobility, stopping of joint pains.


High sensitivity to drug, the period of pregnancy and a lactation, a disease of a liver, injury of skin or existence of an infection in the field of an injection.

Side effects

In rare instances emergence of moderate morbidity and hypostasis of a joint, increase in exudate, reddening in an injection site of drug and temperature increase. More rare — local allergic reactions to drug.

Gialgan of Pheidias, application instruction (Way and dosage)

Intra joint administration of drug by a standard technique taking into account anatomic features in a dose — 20 mg / 2 ml (one filled syringe) once a week, only 5 injections.


There are no data.


Gialgan Pheidias cannot be entered into a joint together with other injections in a joint. It is impossible to use disinfectants which part ammonium salts as these substances besiege hyaluronic acid are.

Terms of sale

Issue according to the recipe.

Storage conditions

At a temperature up to 25 °C.

Period of validity

36 months.

Gialgan Pheidias's analogs

Coincidence on the ATH code of the 4th level:

Restilayn, Hyaluronic acid.

About Gialgane Pheidias

About drug at most of patients positive. Introduction of this remedy to a joint, helped many patients to recover mobility and to stop morbidity in a joint. Some patients note side effect of drug.

"… Entered 5 pricks of Gialgan Pheidias. The first three pricks went normally, and the last two were followed by rise in temperature which is in a day normalized. But in general, mobility of a joint improved".


  • Gialgan of Pheidias 20mg/2ml solution for intra joint introduction No. 1 shpritsfidia Pharmaceutici
to show still
Section: For joints
in more detail

Education: Graduated from Sverdlovsk medical school (1968 - 1971) as "Paramedic". Graduated from the Donetsk medical institute (1975 - 1981) as "An epidemiologist, a hygienist". Passed postgraduate study in the Central scientific research institute of epidemiology Moscow (1986 - 1989). An academic degree – the candidate of medical sciences (degree is awarded in 1989, protection – the Central scientific research institute of epidemiology Moscow). Numerous advanced training courses are studied in epidemiology and infectious diseases.

Experience: Work as the manager of department of disinfection and sterilization of 1981 - 1992. Work as the manager of department of especially dangerous infections of 1992 - 2010. Teaching activity at Medical institute 2010 - 2013.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Gialgan of Pheidias surely consult with the attending physician.